Browsing by Author Coates, Alan

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 21 to 40 of 131 < previous   next >
Issue DateTitleAuthor(s)Citation
2015Aromatase inhibitors versus tamoxifen in early breast cancer: patient-level meta-analysis of the randomised trialsCoates, Alan; Aihara, T; Bliss, J; Boccardo, F; Bradley, R; Coombes, R; Cuzick, J; Dowsett, Mitch (Prof); Dubsky, P; et al, Various; Forbes, John F.; Gnant, Michael; Ingle, J.; Kaufmann, Michael; Kilburn, L; School of Public Health: Public HealthAromatase inhibitors versus tamoxifen in early breast cancer: patient-level meta-analysis of the randomised trials, The Lancet, vol.386, 10001, 2015,pp 1341-1352
2011Assessment of letrozole and tamoxifen alone and in sequence for postmenopausal women with steroid hormone receptor-positive breast cancer: the BIG 1-98 randomised clinical trial at 8.1 years median follow-upCoates, Alan; Ejlertsen, Bent; Forbes, John F.; Gelber, Richard; Giobbie-Hurder, Anita; Goldhirsch, Aron; Lang, Istvan; Mauriac, Louis; Neven, Patrick; Price, Karen N.; Rabaglio, Manuela; Regan, Meredith M.; Smith, Ian (Prof); Thurlimann, B.; Wardley, Andrew; School of Public Health: Public HealthAssessment of letrozole and tamoxifen alone and in sequence for postmenopausal women with steroid hormone receptor-positive breast cancer: the BIG 1-98 randomised clinical trial at 8.1 years median follow-up, Lancet Oncology, vol.12, 12, 2011,pp 1101-1108
2013Axillary dissection versus no axillary dissection in patients with sentinel-node micrometastases (IBCSG 23-01): a phase 3 randomised controlled trialCoates, Alan; Baratella, Paola; Chifu, Camelia; Cole, Bernard; et al, Various; Galimberti, Viviana; Intra, Mattia; Luini, Alberto; Sargenti, Manuela; Veronesi, Paolo; Viale, Giuseppe; Zurrida, Stefano; School of Public Health: Public HealthAxillary dissection versus no axillary dissection in patients with sentinel-node micrometastases (IBCSG 23-01): a phase 3 randomised controlled trial, Lancet Oncology, vol.14, 4, 2013,pp 297-305
2004Body Mass Index As A Prognostic Feature In Operable Breast Cancer: The International Breast Cancer Study Group Experience.Coates, Alan; Berclaz, G; Castiglione-Gertsch, Monica; Collins, John; Erzen, Darja; et, al; Holmberg, Stig B.; Li, S; Lindtner, Jurii; Price, K N; Rudenstam, Carl-Magnus; School of Public Health: Public HealthBody Mass Index As A Prognostic Feature In Operable Breast Cancer: The International Breast Cancer Study Group Experience., Annals of Oncology 2005, vol.15,(6),2004,pp 875-884
2009Bone fractures among postmenopausal patients with endocrine-responsive early breast cancer treated with 5 years of letrozole or tamoxifen in the BIG 1-98 trialCoates, Alan; Campone, N; Castiglione-Gertsch, Monica; Forbes, John; Hawle, H; Mouridsen, Henning; Paridaens, R.J.; Price, K. N.; Rabaglio, Manuela; Sun, Zhuoxin; Thurlimann, Beat; School of Public Health: Public HealthBone fractures among postmenopausal patients with endocrine-responsive early breast cancer treated with 5 years of letrozole or tamoxifen in the BIG 1-98 trial, Annals of Oncology, vol.20, 9,pp 1489-1498
2014Bone mineral density and circulating biomarkers in the BIG 1-98 trial comparing adjuvant letrozole, tamoxifen and their sequencesCoates, Alan; Campone, Mario; Debled, M.; DeCensi, Andrea; et al, Various; Guerrieri-Gonzaga, Aliana; McIntosh, Christina; Monnier, Alain; Schönenberger, Astrid; Sun, Zhuoxin; Thurlimann, B.; Tondini, Carlo; School of Public Health: Public HealthBone mineral density and circulating biomarkers in the BIG 1-98 trial comparing adjuvant letrozole, tamoxifen and their sequences, Breast Cancer Research and Treatment, vol.144, 2, 2014,pp 321-329
2007CA15-3 and alkaline phosphatase as predictors for breast cancer recurrence: a combined analysis of seven International Breast Cancer Study Group trialsCoates, Alan; Colleoni, Marco; Collins, John; Crivellari, D; Dellapasqua, S; et, al; Keshaviah, A; Lindtner, J; Mendiola, C; Rotmensz, N; Thuerlimann, B; School of Public Health: Public HealthCA15-3 and alkaline phosphatase as predictors for breast cancer recurrence: a combined analysis of seven International Breast Cancer Study Group trials, Annals of Oncology 2005, vol.18,(4),2007,pp 701-708
2005Cancer prevention: a global perspective.Coates, Alan; Stewart, Bernard W.; School of Public Health: Public HealthCancer prevention: a global perspective., JOURNAL OF CLINICAL ONCOLOGY 2005, vol.23,(2),2005,pp 392-403
2011Capecitabine Versus Classical Cyclophosphamide, Methotrexate, and Fluorouracil As First-Line Chemotherapy for Advanced Breast CancerCoates, Alan; Gebski, Val; Grimison, Peter; Stockler, Martin; Wilcken, Nicholas; Zannino, Diana; Ackland, Stephen; Byrne, Michael J.; Fitzharris, B; Fong, A.; Forbes, John; Francis, Prudence; Gainford, Corona; Harvey, V; Nowak, Anna; Paksec, Lisa; Simes, John; Sourjina, Tatiana; Van Hazel, Guy; School of Public Health: Public Health; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials Centre; Western Clinical School: Medicine (Westmead); School of Public Health: NH&MRC Clinical Trials CentreCapecitabine Versus Classical Cyclophosphamide, Methotrexate, and Fluorouracil As First-Line Chemotherapy for Advanced Breast Cancer, Journal of Clinical Oncology, vol.29, 34, 2011,pp 4498-4504
2007Cardiovascular Adverse Events During Adjuvant Endocrine Therapy for Early Breast Cancer Using Letrozole or Tamoxifen: Safety Analysis of BIG 1-98 TrialCoates, Alan; Castiglione-Gertsch, Monica; et, al; Forbes, John F.; Keshaviah, Aparna; Mauriac, Louis; Mouridsen, Henning; Paridaens, Robert; Rabaglio, Manuela; Sun, Zhuoxin; Thurlimann, Beat; School of Public Health: Public HealthCardiovascular Adverse Events During Adjuvant Endocrine Therapy for Early Breast Cancer Using Letrozole or Tamoxifen: Safety Analysis of BIG 1-98 Trial, JOURNAL OF CLINICAL ONCOLOGY 2005, vol.25,(36),2007,pp 5715-5722
2008Chemoendocrine Compared With Endocrine Adjuvant Therapies for Node-Negative Breast Cancer: Predictive Value of Centrally Reviewed Expression of Estrogen and Progesterone Receptors-International Breast Cancer Study GroupCoates, Alan; Braye, Stephen; Brown, Robert; Castiglione-Gertsch, Monica; Gelber, Richard D. (Prof); Goldhirsch, Aron (Prof); Golouh, Rastko; Grigolato, Piergioranni; Gusterson, Barry A.; Kovacs, Aniko; Maiorano, Eugenio; Mastropasqua, Mauro G.; Ohlschlegel, Christian; Perin, Tiziana; Pillay, Komala; Price, Karen N.; Regan, Meredith M.; Rusca, Tiziana; Viale, Giuseppe; School of Public Health: Public HealthChemoendocrine Compared With Endocrine Adjuvant Therapies for Node-Negative Breast Cancer: Predictive Value of Centrally Reviewed Expression of Estrogen and Progesterone Receptors-International Breast Cancer Study Group, Journal of Clinical Oncology, vol.26, 9, 2008,pp 1404-1410
2003Chemotherapy for advanced breast cancer- how long should it continue?Coates, Alan; Stockler, Martin; Wilcken, Nicholas; School of Public Health: Public Health; School of Public Health: NH&MRC Clinical Trials Centre; Western Clinical School: Medicine (Westmead)Chemotherapy for advanced breast cancer- how long should it continue?, Breast Cancer Research and Treatment, vol.81,(Suppl 1),2003,pp S49-S52
2014Chemotherapy for isolated locoregional recurrence of breast cancer (CALOR): a randomised trialCoates, Alan; Aebi, Stefan; Anderson, Stuart J; Canada, Jose; et al, Various; Gelber, S.; Lang, Istvan; Martin, Miguel; Nortier, Johan; Paterson, Alexander; Rimawi, Mothaffar F; Robidoux, Andre; School of Public Health: Public HealthChemotherapy for isolated locoregional recurrence of breast cancer (CALOR): a randomised trial, Lancet Oncology, vol.15, 2, 2014,pp 156-163
2017Cholesterol, cholesterol-lowering medication use, and breast cancer outcome in the BIG 1-98 studyCoates, Alan; Ahern, T; Borgquist, Signe; Colleoni, Marco; Debled, Marc; Ejlertsen, Bent; et al, Various; Garber, Judy; Giobbie-Hurder, Anita; Lang, Istvan; von Moos, Roger; NH&MRC Clinical Trials CentreCholesterol, cholesterol-lowering medication use, and breast cancer outcome in the BIG 1-98 study, Journal of Clinical Oncology, vol.35, 11, 2017,pp 1179-1188
2010Classical Cyclophosphamide, Methotrexate, and Fluorouracil Chemotherapy Is More Effective in Triple-Negative, Node-Negative Breast Cancer: Results From Two Randomized Trials of Adjuvant Chemoendocrine Therapy for Node-Negative Breast CancerCoates, Alan; Cole, Bernard; Colleoni, Marco; Crivellari, Diana; Gelber, Richard D. (Prof); Goldhirsch, Aron (Prof); Gusterson, Barry; Maiorano, Eugenio; Mastropasqua, Mauro G.; Price, Karen N.; Regan, Meredith M.; Viale, Giuseppe; School of Public Health: Public HealthClassical Cyclophosphamide, Methotrexate, and Fluorouracil Chemotherapy Is More Effective in Triple-Negative, Node-Negative Breast Cancer: Results From Two Randomized Trials of Adjuvant Chemoendocrine Therapy for Node-Negative Breast Cancer, Journal of Clinical Oncology, vol.28, 18, 2010,pp 2966-2973
2011Cognitive function in postmenopausal breast cancer patients one year after completing adjuvant endocrine therapy with letrozole and/or tamoxifen in the BIG 1-98 trialCoates, Alan; Aldridge, Julie; Bernhard, Jurg; Cardoso, Fatima; Gelber, RD; Goldhirsch, Aron (Prof); Harvey, V; Pagani, O.; Phillips, Kelly-Anne; Price, K N; Ribi, Karin; Sun, Zhuoxin; Thompson, Alastair; Thurlimann, B.; School of Public Health: Public HealthCognitive function in postmenopausal breast cancer patients one year after completing adjuvant endocrine therapy with letrozole and/or tamoxifen in the BIG 1-98 trial, Breast Cancer Research and Treatment, vol.126, 1, 2011,pp 221-226
2010Cognitive function in postmenopausal women receiving adjuvant letrozole or tamoxifen for breast cancer in the BIG 1-98 randomized trialCoates, Alan; Bernhard, Jurg; Cardoso, Fatima; Gelber, Richard D. (Prof); Goldhirsch, A; Harvey, V; Pagani, O.; Phillips, Kelly-Anne; Price, Karen; Ribi, Karen; Stephens, Alisa; Sun, Zhuoxin; Thompson, Alastair; Thurlimann, B.; School of Public Health: Public HealthCognitive function in postmenopausal women receiving adjuvant letrozole or tamoxifen for breast cancer in the BIG 1-98 randomized trial, The Breast, vol.19, 5,pp 388-395
2003Comments on the St. Gallen Consensus 2003 on the primary therapy of early breast cancerCoates, Alan; Gelber, Richard D. (Prof); Goldhirsch, Aron (Prof); Senn, H.-J.; Thurlimann, B.; Wood, W. C.; School of Public Health: Public HealthComments on the St. Gallen Consensus 2003 on the primary therapy of early breast cancer, Breast, vol.12,(N/A),2003,pp 569-582
2005Comparing patients' and their partners' preferences for adjuvant chemotherapy (ACT) in early breast cancer (EBC)Beith, Jane; Boyle, Frances; Butow, Phyllis; Coates, Alan; Duric, Vlatka; Heritier, Stephane; Sharpe, Louise; Simes, Robert John; Stockler, Martin; Wilcken, Nicholas; Central Clinical School: Medicine; Central Clinical School: Medicine; Psychology; School of Public Health: Public Health; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials Centre; Psychology; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials Centre; Western Clinical School: Medicine (Westmead)Comparing patients' and their partners' preferences for adjuvant chemotherapy (ACT) in early breast cancer (EBC), Journal of Clinical Oncology (Print), vol.23,(16S),2005,pp 546S-546S
2008Comparing patients' and their partners' preferences for adjuvant chemotherapy in early breast cancerButow, Phyllis; Coates, Alan; Duric, Vlatka; Heritier, Stephane; Sharpe, Louise; Simes, Robert John; Stockler, Martin; Beith, Jane M.; Boyle, Frances; Wilcken, Nocholas; Psychology; School of Public Health: Public Health; School of Public Health: NH&MRC Clinical Trials Centre; The George Institute for Global Health; Psychology; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials CentreComparing patients' and their partners' preferences for adjuvant chemotherapy in early breast cancer, Patient Education and Counseling, vol.72, 2, 2008,pp 239-245